A.R.T. Advisors’s Melinta Therapeutics, Inc. Common Stock MLNT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
2019
Q4
$14K Sell
2019
Q3
$140K Buy
2019
Q1
Sell
2018
Q4
$35K Buy
2018
Q3
$106K Buy
2018
Q2
Sell
2018
Q1
$142K Sell
2017
Q4
$934K Buy